Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States THOROFARE, N.J.,, July 18, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...

Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test THOROFARE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...